WO2000021436A1 - Placing a guide member into the heart - Google Patents
Placing a guide member into the heart Download PDFInfo
- Publication number
- WO2000021436A1 WO2000021436A1 PCT/US1999/022945 US9922945W WO0021436A1 WO 2000021436 A1 WO2000021436 A1 WO 2000021436A1 US 9922945 W US9922945 W US 9922945W WO 0021436 A1 WO0021436 A1 WO 0021436A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heart
- guide member
- conduit
- heart chamber
- wall
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3415—Trocars; Puncturing needles for introducing tubes or catheters, e.g. gastrostomy tubes, drain catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2493—Transmyocardial revascularisation [TMR] devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/94—Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
- A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30079—Properties of materials and coating materials magnetic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/009—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
Definitions
- the invention relates to treating heart disease, and more particularly systems, devices and methods for reestablishing or improving blood flow to the myocardium.
- Coronary artery disease is currently treated by interventional procedures such as percutaneous transluminal coronary angioplasty (PTCA), atherectomy and intracoronary stenting, as well as surgical procedures including coronary artery bypass grafting (CABG).
- PTCA percutaneous transluminal coronary angioplasty
- CABG coronary artery bypass grafting
- the goal of these procedures is to reestablish or improve blood flow through occluded (or partially occluded) coronary arteries, which is accomplished, for example, by enlarging the blood flow lumen of the artery or by forming a bypass that allows blood to circumvent the occlusion.
- What procedure(s) is used typically depends on the severity and location of the blockages. When successful, these procedures restore blood flow to myocardial tissue that had not been sufficiently perfused due to the occlusion.
- the invention provides a system and method for placing a guide member through a coronary vessel and the wall of patient's heart into a heart chamber.
- the guide member may then be used to deliver devices into the heart chamber to carry out various medical procedures.
- an introducer is configured for placement through the wall of a patient's heart so as to extend into a heart chamber.
- the introducer receives a guide member sized and configured to be passed through the introducer, the coronary vessel and the heart wall into the heart chamber.
- the introducer is constructed to position the guide member at a desired location within the heart chamber that allows the guide member to be removed from the chamber.
- a first end of a guide member is passed through a coronary vessel and the wall of the heart into a heart chamber.
- a second end of the guide member is maintained outside the heart chamber, and the first end of the guide member is then passed back out of the heart chamber.
- One of the ends of the guide member may be used to introduce medical devices into the heart chamber.
- the invention provides a system and method for placing a conduit in the wall of a patient's heart to communicate a coronary vessel with a heart chamber.
- One preferred system constructed according to this embodiment includes an introducer configured for placement through the wall of a patient's heart into a heart chamber, a guide member sized and configured to be positioned in the introducer and placed through the heart wall into the heart chamber, and a conduit.
- the conduit is configured for placement in the heart wall to communicate the heart chamber with a coronary vessel.
- Fig. 1 is a schematic view of a patient prepared to undergo a cardiovascular surgical procedure, the patient's heart being exposed via a retractor positioned in a thoracotomy formed in the patient's chest;
- FIGs. 2-4 are perspective views sequentially illustrating the use of a system constructed according to a first embodiment of the invention for placing a guide member within a heart chamber, wherein a portion of the heart wall is broken away for clarity;
- Fig. 5 is a perspective view of the heart shown in Fig. 4 after the guide member has been positioned through the heart wall so as to extend into the heart chamber and the system has been removed;
- Fig. 6 is a perspective view illustrating the use of another system for placing a guide member within the heart chamber, wherein a portion of the heart wall is broken away for clarity;
- Fig. 7 is a perspective view illustrating the use of yet another system for placing a guide member within the heart chamber, wherein a portion of the heart wall is broken away for clarity;
- Fig. 8 is a perspective view of the heart shown in Figs. 6 and 7 after the guide member has been positioned through the heart wall so as to extend into the heart chamber and the system has been removed;
- Fig. 9 is a perspective view illustrating a conduit placement system constructed according to a second embodiment of the invention for placing a conduit in a heart wall, the system being used with a guide member positioned in the heart chamber as shown in Fig. 5;
- Fig. 9A is an enlarged view of a portion of the system shown in Fig. 9;
- Figs. 10 and 11 are perspective views sequentially illustrating using the system shown in Fig. 9 to place a conduit in the heart wall;
- Figs. 10A and 11 A are enlarged sectional views of the system shown in
- Fig. 12 is a perspective view illustrating the conduit placed in the heart wall by the system shown in Figs. 9-11;
- FIG. 12A is an enlarged sectional view of the conduit of Fig. 12
- Fig. 13 is a perspective view illustrating another conduit placement system for placing a conduit in a heart wall, the system being used with a guide member positioned in the heart chamber as shown in Fig. 8;
- FIG. 13A is an enlarged view of a portion of the system of Fig. 13;
- Figs. 14, 15 and 16 are perspective views sequentially illustrating using the conduit placement system shown in Fig. 13 to place a conduit in the heart wall;
- Figs. 14A, 15A and 16A are enlarged sectional views of the system shown in Figs. 14, 15 and 16, respectively;
- Fig. 17 is a perspective view illustrating the conduit placed in the heart wall by the system shown in Figs. 13-16;
- Fig. 17A is an enlarged sectional view of the conduit of Fig. 17;
- Figs. 18A-18F are elevation views, in section, sequentially illustrating yet another conduit and conduit placement system, wherein Fig. 18F shows the conduit positioned in the heart wall.
- the present invention provides methods and devices for placing a guide member through a coronary vessel and a heart wall so that the guide member extends into a heart chamber containing blood, as well as methods and devices for placing a conduit in the heart wall to establish a blood flow path between a coronary vessel and a heart chamber.
- the guide member is preferably introduced through the coronary vessel which allows precise control of the guide member.
- coronary vessel refers to any vessel in the vascular structure of the heart, including but not limited to the arterial vascular structure including coronary arteries, septal perforators.
- the LAD 30 illustrated in the Figures is but one example of a possible vessel which may receive a guide member or be placed in communication with a heart chamber.
- the LAD 30 is placed in communication with a heart chamber that contains blood, which, in the illustrated embodiments, is the left ventricle 12.
- a conduit in communication with any source of blood (arterial or venous), for example, another heart chamber such as the left atrium, or the aorta, pulmonary veins, etc.
- Fig. 1 schematically depicts a patient who has been prepared to undergo a cardiovascular surgical procedure.
- a thoracotomy T formed in the patient's chest by making an incision between two ribs (not shown) provides access to the thoracic cavity.
- a retractor such as the rib retractor R shown in Fig.
- the retractor may be used to spread the ribs and increase access to the heart H and great vessels.
- the retractor is preferably of a type that in addition to spreading the sides of the incision along a first plane also raises one side of the incision with respect to the other side to increase the working space around the heart.
- Any suitable retractor may be used, for example, one of the commercially available rib retractors currently used in minimally invasive cardiac surgery.
- the retractor R provides considerable access to the surfaces of the heart H and great vessels including the aorta A.
- the left side of the heart as well as the left coronary artery LCA is easily accessible via the thoracotomy T.
- a first embodiment of the invention provides methods and devices for placing a guide member through a coronary vessel and a heart wall so that the guide member extends into a heart chamber containing blood.
- the guide member provides a pathway for delivering and guiding devices into the heart chamber, for example, a system for placing a conduit to establish a blood flow path that communicates the heart chamber with the coronary vessel.
- the guide member is positioned in a heart chamber that contains oxygenated blood, i.e., blood containing some level of oxygen.
- Fig. 2 is an anterior view of a heart 10 showing the left ventricle 12, right ventricle 14, right atrium 16, aorta 18, pulmonary trunk 20 and pulmonary veins 22.
- Fig. 2 shows the heart 10 in the diastolic (relaxed) phase of the heart cycle, during which the aortic valve 24 is closed. These views also show the left coronary artery 26 including the circumflex branch 28 and the anterior descending branch (LAD) 30.
- the right coronary artery 32 is visible as well.
- the coronary arteries 26, 28, 30, 32 run along the heart wall 34 and deliver oxygenated blood to the tissue comprising the heart wall, i.e., the epicardium, myocardium, and endocardium.
- a blockage or occlusion 36 is shown in the LAD 30 which results in a partial or complete blockage of the artery lumen, a condition often referred to as narrowing of the arteries. This results in inadequate or no blood flow to the heart wall tissue fed by the portion of the LAD that is downstream of the blockage 36.
- the embodiment depicted in Figs. 2-5 includes an introducer 110 positioned so as to extend through the outer and inner walls 38, 40 of the LAD 30, and through the heart wall 34 into the left ventricle 12.
- the introducer 110 may be a small profile, hollow shaft, for example a stainless steel hypo tube, and preferably has as small a diameter as possible in order to minimize damage to the coronary vessel.
- the introducer 110 may have an OD within the range of from about 0.5 mm to about 3.0 mm and an ID within the range of from about 0.4 mm to about 2.9 mm.
- the introducer 110 is sized to receive a guide member in a sliding manner and has an end 118 located in the heart chamber for directing the guide member through the lumen of the
- the guide member is used to deliver devices into the heart chamber.
- the guide member may be a single member or a plurality of members that cooperate to guide devices into the heart chamber.
- the embodiment illustrated in Figs. 2- 5 comprises a first guide member and a second guide member coupled together, one of the members remaining positioned in the patient's heart to introduce devices into the heart chamber.
- the first guide member is a guide wire 120 constructed of any suitable material such as stainless steel
- the second member is a catheter 122 coupled to the guide wire 120.
- the proximal end 124 of the catheter 122 is coupled to the distal end 126 of the guide wire 120 by a suitable detachable connection, such as a standard leur lock.
- the guide wire 120 preferably has a small diameter, for example, approximately 0J5 mm, as does the catheter 122, for example, 2 French.
- the distal end 128 of the catheter 122 is provided with a member that will be engaged by blood flowing from the left ventricle 12 through the aortic valve 24 into the aorta 18.
- the member is a balloon 130 inflated via an inflation lumen (not shown) that is coupled to a source of pressurized fluid such as a syringe pump.
- An expandable member e.g., balloon 130
- balloon 130 is desirable because it may be collapsed for introduction into the heart chamber, thereby allowing a smaller opening to be formed through the wall of the coronary vessel.
- a balloon e.g., an umbrella-shaped member, a soft plastic tube or a foam member.
- the preferred embodiment uses a member that is movable between collapsed and expanded orientations, but a non-collapsible member could be used as well.
- Fig. 2 shows the catheter 122 after it has been passed through the introducer 110 to place the balloon 130 within the ventricle 12, the balloon being shown inflated to its expanded orientation.
- the heart 10 is in diastole; as such, the pressure in the left ventricle 12 is relatively low as it receives oxygenated blood from the left atrium (not shown).
- the balloon 130 remains in the left ventricle 12 until the heart goes into the systolic (contracted) phase of the heart cycle, shown in Fig. 3.
- the left ventricle 12 contracts to expel oxygenated blood into the aorta 18.
- the balloon 130 and catheter 122 are expelled from the ventricle along with the blood.
- the balloon 130 and catheter 122 are forced from the left ventricle 12 and pass through the aortic valve 24 into the aorta 18, which pulls a portion of the guide wire 120 into the ventricle.
- the position of the guide member may be monitored by ultrasound, TEE, or other means, and the guide member may be provided with a steering mechanism (not shown) if desired.
- a device for removing a portion of the guide member from the heart chamber.
- a snare including an introducer sleeve 132 which is placed through an incision in the aorta 18.
- the sleeve 132 receives a thin wire or filament 134 configured to form a lasso 136.
- the lasso 136 is positioned within the aorta 18 downstream of the aortic valve 24 so that the balloon 130 and catheter 122 pass through the lasso upon being forced out of the left ventricle 12 during systole.
- the device for removing a portion of the guide member from the heart may be used to retrieve the member from a different location than an opening in the aorta as shown in the Figures.
- a magnet may be used to remove the guide member.
- Fig. 4 which depicts the heart 10 in diastole
- the wire 134 is withdrawn into the sleeve 132 to securely grasp the catheter 122.
- the entire assembly of the sleeve 132, wire 134, catheter 122 and the guide wire 120 is pulled to a location external to the heart. In the illustrated embodiment, as seen in Fig. 4, this is achieved by removing the assembly through the incision in the aorta 18, which pulls the distal end 126 of the guide wire 120 into the left ventricle 12 and then out of the aorta 18.
- a proximal section of the guide wire 120 including proximal end 138 is maintained outside the heart.
- this embodiment of the invention results in a guide member (e.g., wire 120) extending through the wall of a coronary vessel (e.g., LAD 30) and the heart wall, into a heart chamber (e.g., left ventricle 12), and out of the heart chamber to a location external to the heart. In this position the guide member provides a pathway for delivering medical devices into the heart chamber for carrying out medical procedures.
- a coronary vessel e.g., LAD 30
- a heart chamber e.g., left ventricle 12
- the guide member and the introducer preferably have small enough profiles so that only a small, easily repaired incision or opening needs to be formed in the walls of the coronary vessel to place the guide member in the heart chamber, and preferably an opening that does not need to be closed by sutures.
- the portion of the guide member located external to the heart e.g., distal end 126 of guide wire 120, is used to deliver medical devices into the heart chamber and the coronary vessel without going through the outer wall of the coronary vessel. As such, it is not necessary to form a large opening(s) in the wall of the coronary vessel to deliver such devices into the heart chamber.
- devices are guided over the distal end 126 of the guide wire 120 into the aorta 18, and then into the left ventricle 12 to a desired location.
- the devices are then used to place a conduit (or form a channel) in the heart wall to communicate the interior of a coronary vessel with a heart chamber containing oxygenated blood.
- This embodiment of the invention may of course take various forms and configurations other than those specifically depicted in Figs. 2-5.
- a guide member comprising a guide wire and a catheter
- one of these components could be omitted.
- the catheter could be used alone by introducing medical devices over the end of the catheter with the balloon.
- the guide member may be sufficiently stiff to allow its introduction through the coronary vessel walls and the heart wall without an introducer, for example, by forming a conventional guide wire, catheter, cannula, etc., with a desired amount of stiffness or flexibility.
- the guide member may be formed of one material or comprise a composite member, such as a flexible shaft portion and a soft tip.
- a device may be used to support the walls of the coronary vessel during introduction of the guide member (and/or the introducer), thereby facilitating quick and easy access and penetration of the vessel.
- Suitable devices for supporting the heart wall and/or vessel walls are disclosed in commonly owned, copending application U.S. Application No. 09/172,098, filed on October 13, 1998 and entitled "DEVICES AND METHODS FOR USE IN PERFORMING TRANSMYOCARDIAL CORONARY BYPASS," the subject matter of which is incorporated herein by reference.
- the vessel may be supported internally or externally in order to facilitate placement of delivery devices through the vessel walls and the heart wall.
- FIG. 6 An example of another system and method for placing a guide member through the wall of a heart according to this embodiment is shown in Fig. 6.
- an introducer 110A is positioned through the walls of the coronary artery LAD and a guide member is slid through the introducer.
- the guide member may include two guide members coupled together, as in the previous embodiment, or a single guide member.
- Fig. 6 shows a single guide member in the form of a guide wire 120A with a proximal end 126A and a distal end 138A.
- the introducer 110A is configured to direct the guide member to a particular location within the heart.
- Fig. 6 shows a single guide member in the form of a guide wire 120A with a proximal end 126A and a distal end 138A.
- the introducer 110A is configured to direct the guide member to a particular location within the heart.
- the introducer 110A is curved so that the distal end 118A thereof can be positioned to direct the guide member into the heart wall at a desired location, such as an area near the apex of the heart.
- the illustrated introducer 110A is generally J-shaped; it may, however, be shaped differently.
- the proximal portion of the introducer is manipulated to aim the distal end
- the guide wire 120 A preferably has sufficient strength to allow the end 126A to be pushed through the tissue of the heart wall. This may be facilitated by locating the distal end 118A of the introducer 110A relatively close to the heart wall so that a relatively short length of the guide wire extends from the introducer before contacting the surface of the heart wall.
- a portion of the guide wire 120A is maintained outside the LAD 30 and the left ventricle 12.
- a proximal portion (including end 138 A) of the guide wire 120 A is maintained outside the heart.
- the introducer 110A is removed, leaving the guide wire positioned as shown in Fig. 8.
- One benefit of the system and method shown in Fig. 6 is that a snare (or other device) for removing a portion of the guide member from the heart chamber is not required. This obviates the need for precisely directing a portion of the guide member to a specific location within (or without) the heart chamber to allow its removal.
- the introducer or the guide member may be preshaped to direct the guide member to a particular area within the heart chamber
- the introducer may be in the form of curved hollow needle that is sized and configured to be passed through the coronary vessel and the heart wall into the heart chamber, and then out of the heart chamber.
- the introducer thus may extend from outside the heart chamber, into the heart chamber, and then out of the heart chamber.
- a guide member or conduit delivery device may then be positioned in the heart chamber using the introducer.
- the guide member is removed from the heart chamber by a snare or like device.
- An introducer 110 is used in the manner described above with respect to Figs. 2-5 to place the distal end 126A of the guide wire 120A within the left ventricle 12 at a desired location, for example, adjacent the apex of the heart.
- the guide wire 120 A is preferably preshaped to assume a desired position when inserted into the heart chamber. From here the distal end 126A of the guide wire 120 A is removed to a location external to the heart by a snare assembly comprising components 132, 134, 136 that are used to grasp and remove a portion of the guide wire 120A from the left ventricle 12.
- the guide member may be manipulated or steered to a desired location by a suitable mechanism (not shown), or formed of a shape memory alloy that directs the guide member to the desired location after insertion into the heart.
- a portion of the guide wire 120A is removed while maintaining another portion of the guide wire outside the LAD 30 and the left ventricle 12.
- a proximal section of the guide wire 120 A including end 138 A is preferably maintained outside the heart.
- a guide member placed according to the systems and methods described above provides a pathway for delivering medical devices into the heart chamber without passing the devices through the walls of the coronary artery.
- the systems and methods illustrated in Figs. 2-8 are only exemplary and that this embodiment of the invention encompasses placing a guide member within a patient's heart so that different medical devices may be delivered into a heart chamber.
- the particular procedure carried out or the systems or devices used to place the guide member will vary depending on the application.
- a guide member positioned as discussed above is used to deliver a conduit (or form a channel) that forms a blood flow path between a heart chamber and the interior of a coronary vessel.
- a delivery system is designated by the reference numeral 140 and comprises a conduit 142 supported on a delivery device 144.
- the conduit 142 is preferably a rigid (i.e., not expandable) tubular element including a body portion 146 having a first end 148 and a second end 150.
- the conduit body portion 146 includes one or more openings 152 passing through the wall thereof.
- the body portion 146 has a plurality of holes located adjacent the second end 150, which end is preferably tapered as shown in Figs. 9 and 9A. Blood flows into the interior of the conduit 142 via the first end 148 and out of the conduit through openings 152 into the interior of the LAD 30.
- the delivery device comprises a shaft 154
- Fig. 9A having a substantially complementarily shaped exterior to support the conduit 142 during introduction into the left ventricle 12 and delivery into the heart wall 34.
- the shaft 154 has an elongated body that extends beyond the length of the conduit 142. The elongated body is slidable over a guide member (guide wire 120 in the Figures) that has been positioned in a manner corresponding to that described above with respect to Fig. 5.
- the body of the shaft 154 has a clamp 158 which secures the shaft to the guide wire 120 in order to deliver the conduit 142 into the heart wall 34.
- the clamp 158 has a rotatable knob 160 to selectively clamp the shaft 154 to the guide wire 120. Any other suitable mechanism may be used to couple the shaft 154 to the guide wire 120.
- Fig. 9 shows the shaft 154 secured to the guide wire 120 and ready to be introduced into the left ventricle 12 via the opening in the aorta 18.
- the proximal end 138 of the guide wire 120 is pulled in the direction of the arrow in Fig. 10. This moves the guide wire 120, shaft 154 and conduit 142 into the aorta 18, past the aortic valve 24 and into the left ventricle 12. As the distal end 126 of the guide wire 120 is pulled further, the conduit 142 enters the heart wall 34, as shown in Figs. 10-lOA.
- the position of the conduit 142 relative to the heart wall 34 and the LAD 30 can be controlled by manipulating the distal end 126 of the guide wire 120 or the proximal end of the shaft 154 (or end 138 of the wire).
- the position of the conduit 142 within the heart wall 34 thus can be selectively adjusted by pulling or pushing an end of the guide wire 120 (or shaft 154) with respect to the heart wall.
- Fig. 10A shows the conduit 142 positioned in the heart wall 34 so that a portion of the second end 150 is located within the lumen of the LAD 30. In this embodiment at least some of the openings 152 are located within the LAD 30 and deliver blood from the left ventricle 12 into the artery.
- the shaft 154 is removed from the conduit by pulling the shaft into the left ventricle 12 and toward the aorta 18. This may be accomplished in various ways.
- the clamp 158 may be disengaged from the guide wire 120 by rotating the knob 160 to allow the shaft 154 to be slid off the proximal end of the wire in the direction of the arrow.
- the shaft 154 and the guide wire 120 may be removed as a unit by pulling the elements through the conduit 142, into the left ventricle 12 and out of the aorta 18, thereby obviating the need to release the clamp 158 from the wire 120.
- the second end 150 of the conduit 142 includes a low profile end 162 with a small diameter that is easily passed through the outer wall 38 of the LAD 30 after the conduit has been moved to the position of Figs. 10- 10A.
- the end 162 preferably comprises a thin-walled section of tubing that collapses or folds and conforms to the exterior of the guide wire 120.
- the end 162 may be separate from or integral with the material forming the conduit 142.
- the end 162 is detachable from the conduit 142 by suitable means, e.g., a perforated or scored section.
- the portion of the end that is outside the LAD 30 may be grasped and removed by pulling it in the direction of the arrow in Fig. 11, preferably while holding the proximal end 138 of the guide wire 120 or the portion of the shaft 154 located external to the heart, as shown in Fig. 11.
- the end 162 may be omitted with the conduit 142 open or closed at the end positioned in the artery.
- the opening in the outer wall 38 of LAD 30 is repaired as shown in Figs. 12-12A. If the shaft 154 has been removed previously without removing the guide wire 120, the guide wire is removed by pulling it out of the opening in the aorta 18 or the openings in the walls of the LAD 30. The opening in the aorta is then repaired. The resulting placement of the conduit 142 provides a blood flow path between the left ventricle 12 and the LAD 30, which path is located distal to the occlusion 36 so that the myocardial tissue fed by the distal portion of the LAD is perfused.
- the illustrated conduit 142 is preferably formed of a rigid material that is strong enough to resist the force exerted by the myocardial tissue during systole so that the blood flow path is not blocked when the heart contracts.
- the conduit 142 may be formed of various materials, for example, stainless steel, titanium, nitinol, polymers, ceramics, etc.
- the conduit may be constructed of a material that partially collapses when the heart contracts during systole and returns to its normal configuration during diastole, or the conduit may achieve specific flow characteristics by regulating blood flow with a valve or other means.
- the conduit may have a constant cross-section fully open at both ends, and it may be provided with any size, shape and number of openings 152 depending on the desired flow characteristics.
- the openings 152 may be located along the entire length or only a portion of the length of the conduit 142.
- the shape of the conduit itself may be varied from that shown in the Figures.
- the conduit 142 may have a constant cross-section over its length rather than a tapered portion, or one or both ends of the conduit may have enlarged portions, e.g., flanges, extensions or outwardly tapered sides for aiding in engaging the conduit with the wall of the heart or the wall of the coronary vessel.
- the conduit may have an enlarged central portion with reduced size ends, and the central portion may act as a blood reservoir.
- the conduit 142 is shown extended into the lumen of the LAD 30, it may instead be flush with or slightly below the inner wall 40 of the LAD 30 (or flush with the surface of occlusion 36 in the LAD 30).
- the shaft 154 and the conduit 142 are coupled to the guide wire 120 so as to move therewith, the system may be used without coupling these elements.
- the guide wire 120 may be positioned as shown and held while the delivery system 140 is slid over the wire into the aorta and then into the left ventricle 12.
- the conduit 142 may then be pushed into the heart wall 12.
- FIGs. 13-17A show another preferred system and method for delivering a conduit into a heart chamber and placing the conduit in the heart wall to communicate the heart chamber with the interior of a coronary vessel.
- the system is designated by the reference numeral 170 and comprises a conduit 172 supported on a delivery device 174.
- the conduit 172 is preferably an expandable tubular member in the form of a stent including a plurality of elements 176 that move relative to each other as the stent moves between collapsed and expanded orientations.
- the conduit 172 preferably comprises a stent having a plurality of struts that move to a load supporting position when the stent assumes its expanded orientation, the struts defining a plurality of open areas through which blood may flow.
- the conduit 172 is delivered into the left ventricle and placed in the heart wall while in its collapsed orientation, and then is opened to its expanded orientation.
- the conduit 172 is supported on the delivery device 174 in its collapsed orientation.
- the conduit 172 is a balloon-expandable stent; thus, the device 174 comprises a balloon 178 that is inflated via an inflation lumen that communicates with a source of pressurized fluid (not shown).
- the stent could be expanded by a non-inflatable mechanism rather than a balloon.
- the conduit 172 may be in the form of a self-expanding stent that is retained in its collapsed orientation by a cover or sleeve disposed around the stent.
- conduit 172 it is desirable to cover the conduit 172 during delivery into the left ventricle and the heart wall to prevent the elements 176 from snagging or damaging tissue as they are passed into heart.
- the conduit comprises a balloon-expandable stent as illustrated, a sheath 180 is preferably placed over the conduit to cover the elements 176.
- the delivery device 174 comprises an elongated shaft provided with a mechanism for securing the device to the guide wire 120 A.
- a preferred mechanism is supported by a Y-connector 182 and includes a clamp 184 in the form of a rotatable knob that is operated as described above with respect to the embodiment of Figs. 9-12A.
- the clamp 184 is used to secure the shaft to the guide wire 120 A so that the components can be manipulated as a unitary assembly.
- the Y-connector 182 may be provided with a leg 186 for being coupled to a source of pressurized fluid, such as a syringe pump.
- the elongated shaft of the delivery device 174 is slidable over the guide wire 120A which, in the illustrated embodiment, has been positioned in a manner corresponding to that described above with respect to Fig. 8.
- the clamp 184 secures the shaft 174 to the guide wire 120A in order to deliver the conduit 172 into the heart wall 34.
- the clamp 184 has a rotatable knob to selectively clamp the shaft 174 to the guide wire
- FIG. 13 shows the shaft 154 secured to the guide wire 120 and in the process of being introduced into the left ventricle 12 via the opening in the aorta 18.
- the distal end 126A of the guide wire is pulled in the direction of the arrow in Fig. 13. This moves the guide wire 120A, shaft 174 and conduit 172 into the left ventricle 12.
- the conduit 172 enters the heart wall 34 with the end of the sheath 180 dilating the opening, as shown in Figs. 14-14A.
- the position of the conduit 172 relative to the heart wall 34 and the LAD 30 can be controlled by manipulating the proximal end of the shaft and the distal end 126A of the guide wire 120 A. That is, the position of the conduit 172 within the heart wall 34 can be selectively adjusted by pulling one end of the guide wire 120A (or and end of the shaft 154) toward or away from the heart wall.
- Fig. 14A shows the conduit 172 positioned in the heart wall 34 so that an end 188 of the conduit is located within the lumen of the LAD 30. At least some of the openings defined between the stent elements 176 are located within the LAD 30 so that blood may flow into the LAD through the end and the wall of the conduit.
- the sheath 180 is removed to expose the conduit to the heart wall tissue. The sheath may be removed in any suitable manner. In the illustrated embodiment, the sheath 180 has an end 190 which can be grasped outside the LAD 30 and pulled.
- the entire sheath is preferably formed of a soft, collapsible material to permit the sheath to be folded or bunched up in order to pass through the opening in the walls of the LAD 30.
- Suitable materials include urethane, polyethylene, polytetrafluoroethylene, etc.
- Fig. 15 shows the sheath 180 after it has been removed from the conduit 172 and the LAD 30. Removing the sheath 180 exposes the conduit 172 and results in tissue moving into the spaces between the stent elements 176, which helps retains the conduit in position.
- Fig. 15A shows the conduit 172 once the sheath 180 has been removed.
- a mechanism is utilized to expand the stent elements 176, preferably to their maximum strength position.
- One suitable mechanism is shown in Fig. 16A and includes the balloon 178.
- the balloon 178 is inflated by a source of pressurized fluid, such as syringe 192, coupled to inflation lumen 186.
- the syringe 192 is actuated to inflate the balloon 178 and expand the conduit 172 to the orientation shown in Figs. 16-16A.
- the syringe 192 is actuated to take down the balloon 178 for removal from the interior of the conduit 172.
- the deflated balloon can be pulled into the ventricle 12 and removed through the opening in the heart wall (adjacent the apex in the Figures).
- the guide wire 120 A may then be removed by pulling either end through the chamber.
- the shaft 174, balloon 178 and guide wire 120A may be removed as a unit by pulling the elements (after the balloon has been deflated) through the conduit 172 and then into and out of the left ventricle 12.
- Figs. 17-17A show the conduit 172 expanded and positioned in the heart wall after the delivery system has been removed from the heart. After the conduit 172 has been fully expanded it firmly engages the tissue of the heart wall. The conduit 172, because it is constructed as a stent, remains expanded despite the force exerted against it by the heart wall during the systolic phase of the heart cycle.
- the size of the conduit is constant over its cross-section and the ends of the conduit extend slightly into the lumen of the LAD 30 and the left ventricle 12. It should be recognized though that the conduit may have a size or shape that varies over its length, and may be positioned with one or both ends extending within, beyond or flush with the ventricle and coronary surfaces of the heart wall.
- FIGs. 9-12A and Figs. 13-17A respectively illustrate two independent conduit delivery systems and methods for placing a conduit within the heart wall to communicate the left ventricle with a coronary artery.
- the conduit delivery system and method of Figs. 9-12A are disclosed in connection with a guide member placed as shown in Fig. 5, while the system and method of Figs. 13-17A are disclosed in connection with a guide member placed as shown in Fig. 8.
- Fig. 8 the specific construction and configuration of the conduit and delivery system may be different from those specifically illustrated.
- Figs. 18A-21 show systems and methods for placing a conduit in the heart wall so as to communicate a heart chamber with a coronary vessel according to a third embodiment of the invention.
- the conduit has a generally funnel- shaped configuration in that one end of the conduit is larger than the other end of the conduit.
- the conduit is positioned in the heart wall to communicate a heart chamber with a coronary vessel.
- the larger end of the conduit is preferably positioned in the heart chamber and the smaller end is positioned in the vessel, although one or both ends could be flush with or within the heart wall.
- a conduit delivery system indicated by reference numeral 200 includes a conduit 202 supported on a delivery device 204.
- the conduit 202 is similar to the conduit 172 in that it is in the form of a stent including a plurality of elements 206 that move relative to each other as the stent moves to its expanded orientation.
- the conduit 202 preferably assumes a maximum load supporting position when fully expanded. Blood may flow through a plurality of open areas defined between the stent elements 206.
- the conduit 202 is supported on the delivery device 204 which itself is supported on a guide member, such as guide wire 208.
- the conduit 202 is supported in a collapsed orientation and, in the illustrated embodiment, is expanded by a balloon 210 that is inflated via an inflation lumen that communicates with a source of pressurized fluid (not shown).
- a non-inflatable mechanism rather than a balloon could expand the conduit 202, or it could be in the form of a self-expanding stent that is retained in its collapsed orientation by a cover or sleeve.
- the conduit 202 preferably is covered during delivery into the left ventricle and the heart wall to prevent the elements 206 from damaging tissue.
- a sheath 212 is placed over the conduit 202 to cover some (and preferably most or all) of the elements 206.
- the delivery device 204 may comprise an elongated shaft provided with a mechanism for securing the device to the guide wire 208 which extends through a heart chamber (such as left ventricle 12) and the wall of a coronary artery (such as LAD 30).
- the conduit 202 is moved into the heart chamber 12 and is placed in the heart wall 34, as shown in Fig. 18 A.
- the position of the conduit 202 relative to the heart wall 34 and the LAD 30 can be controlled and adjusted as explained above.
- the conduit 202 is preferably positioned in the sheath 212 so that a portion 214 including end 216 extends beyond the sheath (Fig. 18 A). This permits the portion 214 of the conduit 202 to be expanded to a larger size than the portion of the conduit within the sheath 212. As shown in Fig. 18B, the balloon 210 is inflated and expands the portion 216 of the conduit 202; however, the sheath 212 prevents or limits expansion of the remaining portion of the conduit. After this step, the sheath 212 is removed from the conduit 202, for example, by pulling and end 218 of the sheath through the opening in the wall 38 of the
- the sheath is preferably made of a strong yet soft, collapsible material that allows the sheath to be folded and removed through the small opening in the wall of the artery.
- the materials described above with respect to the sheath 180 of the previous embodiment may be used.
- the expanded portion 216 of the conduit 202 aids in retaining the conduit in the heart wall while the sheath is removed.
- the balloon 210 is inflated to expand the entire conduit 202, as shown in Fig. 18E.
- the conduit expands along its remaining length (i.e., other than expanded portion 216) to the orientation shown in Fig. 18F.
- the stent elements 206 are forced against the tissue of the heart wall to retain the conduit in position.
- the expanded portion 216 provides an enlarged opening through which blood may flow from the left ventricle 12 into the LAD 30, and also serves to secure the conduit within the heart wall.
- the entire conduit is preferably, though not necessarily, in its maximum radial strength position.
- the balloon 210 is then deflated and removed from the conduit 202, for example, by moving the delivery device 204 and balloon 210 into the left ventricle 12 and then out of the heart (with or without removing the guide wire 208). After this, the opening in the wall 38 of left ventricle 12 is repaired leaving the conduit 202 positioned as shown in Fig. 18F. As can be seen, the conduit 202 assumes a funnel shape by way of the sheath restricting expansion of a portion of the conduit; however, it will be appreciated that this shape may be obtained in an alternative manner. It will be understood that the invention encompasses many variations of the preferred systems and methods described in detail herein.
- a guide member placed as described above may be used to deliver a tissue removal device into the chamber.
- the tissue removal device can be used to core a channel in the heart wall and/or remove a portion of the wall of the coronary vessel. If used in conjunction with placing a conduit in the heart wall, for example, in order to core a channel in the wall that receives the conduit, it should be recognized that the tissue removal device may be separate from or combined with the conduit delivery device. The device may instead be used to form a channel in the heart wall that remains open to provide a blood flow path without using a conduit.
- FIG. 1 is but one exemplary manner of accessing the heart in order to utilize the systems, devices and methods of the invention.
- a thoracotomy is used as opposed to a median sternotomy
- other approaches may be used to access the heart in order to practice the invention.
- an open surgical procedure including a median sternotomy may be used, or a minimally invasive procedure utilizing one or more relatively small access openings or ports may be used.
- Endoscopes or thoracoscopes may be used for visualization if the procedure is truly minimally invasive.
- an endovascular approach may be used to guide various inventive devices to the heart through the patient's vascular system to the heart, for example, by introducing the devices into a peripheral vessel such as the femoral artery.
- the exemplary embodiments are described primarily in connection with their use in a beating heart procedure.
- a guide member or conduit delivery device may include radiopaque markers for monitoring their position.
- a guide member or conduit placed according to the invention may be used to deliver any medical device, such as tissue removal devices, or any pharmaceutical substance, such as angiogenic growth factors or other substances that aid in the perfusion of surrounding myocardial tissue.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000575420A JP2002527135A (en) | 1998-10-13 | 1999-10-12 | Positioning the guide member in the heart |
AU12002/00A AU764910B2 (en) | 1998-10-13 | 1999-10-12 | Placing a guide member into the heart |
CA002347727A CA2347727A1 (en) | 1998-10-13 | 1999-10-12 | Placing a guide member into the heart |
EP99970305A EP1121050A1 (en) | 1998-10-13 | 1999-10-12 | Placing a guide member into the heart |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/170,793 US6808498B2 (en) | 1998-02-13 | 1998-10-13 | Placing a guide member into a heart chamber through a coronary vessel and delivering devices for placing the coronary vessel in communication with the heart chamber |
US09/170,793 | 1998-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000021436A1 true WO2000021436A1 (en) | 2000-04-20 |
Family
ID=22621280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/022945 WO2000021436A1 (en) | 1998-10-13 | 1999-10-12 | Placing a guide member into the heart |
Country Status (6)
Country | Link |
---|---|
US (2) | US6808498B2 (en) |
EP (1) | EP1121050A1 (en) |
JP (1) | JP2002527135A (en) |
AU (1) | AU764910B2 (en) |
CA (1) | CA2347727A1 (en) |
WO (1) | WO2000021436A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6302892B1 (en) | 1999-08-04 | 2001-10-16 | Percardia, Inc. | Blood flow conduit delivery system and method of use |
US7727268B2 (en) | 2003-07-17 | 2010-06-01 | Medtronic Vascular, Inc. | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US8156942B2 (en) | 2003-07-22 | 2012-04-17 | Medtronic Vascular, Inc. | Method of implanting a transmyocardial stent |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6651670B2 (en) * | 1998-02-13 | 2003-11-25 | Ventrica, Inc. | Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication |
US20020144696A1 (en) | 1998-02-13 | 2002-10-10 | A. Adam Sharkawy | Conduits for use in placing a target vessel in fluid communication with a source of blood |
WO1999040868A1 (en) * | 1998-02-13 | 1999-08-19 | Ventrica, Inc. | Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart |
US6406488B1 (en) * | 1998-08-27 | 2002-06-18 | Heartstent Corporation | Healing transmyocardial implant |
US6641610B2 (en) | 1998-09-10 | 2003-11-04 | Percardia, Inc. | Valve designs for left ventricular conduits |
US6290728B1 (en) | 1998-09-10 | 2001-09-18 | Percardia, Inc. | Designs for left ventricular conduit |
JP2003524444A (en) * | 1998-09-10 | 2003-08-19 | パーカーディア,インコーポレイティド | TMR shunt |
US6261304B1 (en) | 1998-09-10 | 2001-07-17 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US6253768B1 (en) | 1999-08-04 | 2001-07-03 | Percardia, Inc. | Vascular graft bypass |
US6605053B1 (en) | 1999-09-10 | 2003-08-12 | Percardia, Inc. | Conduit designs and related methods for optimal flow control |
US6854467B2 (en) * | 2000-05-04 | 2005-02-15 | Percardia, Inc. | Methods and devices for delivering a ventricular stent |
EP1341487B1 (en) * | 2000-12-15 | 2005-11-23 | Angiomed GmbH & Co. Medizintechnik KG | Stent with valve |
US20080249504A1 (en) | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
FR2846520B1 (en) * | 2002-11-06 | 2006-09-29 | Roquette Freres | USE OF MALTODEXTRINS BRANCHED AS BLEACHES OF GRANULATION |
US8377082B2 (en) * | 2003-01-14 | 2013-02-19 | Medtronic, Inc. | Methods and apparatus for making precise incisions in body vessels |
US7967829B2 (en) * | 2003-10-09 | 2011-06-28 | Boston Scientific Scimed, Inc. | Medical device delivery system |
US9138228B2 (en) | 2004-08-11 | 2015-09-22 | Emory University | Vascular conduit device and system for implanting |
US7738969B2 (en) | 2004-10-15 | 2010-06-15 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US7578819B2 (en) | 2005-05-16 | 2009-08-25 | Baxano, Inc. | Spinal access and neural localization |
US8257356B2 (en) | 2004-10-15 | 2012-09-04 | Baxano, Inc. | Guidewire exchange systems to treat spinal stenosis |
US8221397B2 (en) | 2004-10-15 | 2012-07-17 | Baxano, Inc. | Devices and methods for tissue modification |
US8048080B2 (en) | 2004-10-15 | 2011-11-01 | Baxano, Inc. | Flexible tissue rasp |
US7938830B2 (en) | 2004-10-15 | 2011-05-10 | Baxano, Inc. | Powered tissue modification devices and methods |
US8062300B2 (en) | 2006-05-04 | 2011-11-22 | Baxano, Inc. | Tissue removal with at least partially flexible devices |
US9247952B2 (en) | 2004-10-15 | 2016-02-02 | Amendia, Inc. | Devices and methods for tissue access |
US8613745B2 (en) | 2004-10-15 | 2013-12-24 | Baxano Surgical, Inc. | Methods, systems and devices for carpal tunnel release |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
US20080103504A1 (en) * | 2006-10-30 | 2008-05-01 | Schmitz Gregory P | Percutaneous spinal stenosis treatment |
US7887538B2 (en) | 2005-10-15 | 2011-02-15 | Baxano, Inc. | Methods and apparatus for tissue modification |
US20100331883A1 (en) | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
US20110190772A1 (en) | 2004-10-15 | 2011-08-04 | Vahid Saadat | Powered tissue modification devices and methods |
US7555343B2 (en) | 2004-10-15 | 2009-06-30 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US8430881B2 (en) | 2004-10-15 | 2013-04-30 | Baxano, Inc. | Mechanical tissue modification devices and methods |
WO2006044727A2 (en) | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Devices and methods for tissue removal |
US7763037B2 (en) * | 2005-03-18 | 2010-07-27 | Castlewood Surgical, Inc. | System and method for attaching a vein, an artery, or a tube in a vascular environment |
US8092456B2 (en) | 2005-10-15 | 2012-01-10 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
US20080086034A1 (en) | 2006-08-29 | 2008-04-10 | Baxano, Inc. | Tissue Access Guidewire System and Method |
US8366712B2 (en) | 2005-10-15 | 2013-02-05 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US9259317B2 (en) * | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US8852270B2 (en) * | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US8449606B2 (en) * | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US7785366B2 (en) * | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US8216302B2 (en) * | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8092525B2 (en) * | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US9162039B2 (en) * | 2006-08-18 | 2015-10-20 | David M. Hoganson | Flow directed guidewire |
US7846123B2 (en) | 2007-04-24 | 2010-12-07 | Emory University | Conduit device and system for implanting a conduit device in a tissue wall |
US8480730B2 (en) * | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US8728101B2 (en) * | 2007-08-21 | 2014-05-20 | Castlewood Surgical, Inc. | System and method for providing an obturator for enhanced directional capabilities in a vascular environment |
US8486094B2 (en) | 2007-08-21 | 2013-07-16 | Castlewood Surgical, Inc. | System and method for providing an obturator for enhanced directional capabilities in a vascular environment |
JP5282185B2 (en) * | 2007-08-31 | 2013-09-04 | 株式会社バイタル | Ventricular affected part prosthesis and ventricular affected part prosthetic treatment set |
EP2194861A1 (en) | 2007-09-06 | 2010-06-16 | Baxano, Inc. | Method, system and apparatus for neural localization |
US8597347B2 (en) * | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US8192436B2 (en) | 2007-12-07 | 2012-06-05 | Baxano, Inc. | Tissue modification devices |
WO2009075869A1 (en) * | 2007-12-11 | 2009-06-18 | John Lonsbury | Coupon dispensing methods and systems |
US8979828B2 (en) | 2008-07-21 | 2015-03-17 | The Spectranetics Corporation | Tapered liquid light guide |
US9421065B2 (en) | 2008-04-02 | 2016-08-23 | The Spectranetics Corporation | Liquid light-guide catheter with optically diverging tip |
US8591460B2 (en) * | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
US8398641B2 (en) | 2008-07-01 | 2013-03-19 | Baxano, Inc. | Tissue modification devices and methods |
US8409206B2 (en) | 2008-07-01 | 2013-04-02 | Baxano, Inc. | Tissue modification devices and methods |
WO2010009093A2 (en) | 2008-07-14 | 2010-01-21 | Baxano, Inc | Tissue modification devices |
US9314253B2 (en) | 2008-07-01 | 2016-04-19 | Amendia, Inc. | Tissue modification devices and methods |
CA2749673A1 (en) | 2009-03-13 | 2010-09-16 | Baxano, Inc. | Flexible neural localization devices and methods |
JP5614672B2 (en) * | 2009-05-31 | 2014-10-29 | 国立大学法人鳥取大学 | In-body treatment device |
US8394102B2 (en) | 2009-06-25 | 2013-03-12 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
US20110118829A1 (en) * | 2009-11-15 | 2011-05-19 | Thoratec Corporation | Attachment device and method |
US20110118833A1 (en) * | 2009-11-15 | 2011-05-19 | Thoratec Corporation | Attachment device and method |
US8740970B2 (en) * | 2009-12-02 | 2014-06-03 | Castlewood Surgical, Inc. | System and method for attaching a vessel in a vascular environment |
US8152845B2 (en) | 2009-12-30 | 2012-04-10 | Thoratec Corporation | Blood pump system with mounting cuff |
US20120046730A1 (en) | 2010-04-14 | 2012-02-23 | Abbott Vascular | Methods of treating a condition of a vessel in a patient |
WO2012025927A2 (en) * | 2010-08-25 | 2012-03-01 | Cardiapex Ltd. | Minimally invasive surgical techniques |
JP6130302B2 (en) | 2011-01-28 | 2017-05-17 | アピカ カーディオヴァスキュラー リミテッド | System for sealing tissue wall stings |
EP2670346A2 (en) | 2011-02-01 | 2013-12-11 | Georgia Tech Research Corporation | Systems for implanting and using a conduit within a tissue wall |
EP2995327A1 (en) | 2011-03-02 | 2016-03-16 | Thoratec Corporation | Ventricular cuff |
US9162038B2 (en) | 2011-04-11 | 2015-10-20 | The Spectranetics Corporation | Needle and guidewire holder |
US9199019B2 (en) | 2012-08-31 | 2015-12-01 | Thoratec Corporation | Ventricular cuff |
US9981076B2 (en) | 2012-03-02 | 2018-05-29 | Tc1 Llc | Ventricular cuff |
EP2948104B1 (en) | 2013-01-25 | 2019-07-24 | Apica Cardiovascular Limited | Systems for percutaneous access, stabilization and closure of organs |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
JP6302992B2 (en) | 2013-03-15 | 2018-03-28 | エーピーケー アドバンスド メディカル テクノロジーズ,インコーポレイテッド | Connector for implantation into the tissue wall |
JP6731339B2 (en) | 2013-06-14 | 2020-07-29 | カーディオソリューションズ インコーポレイテッドCardiosolutions, Inc. | Mitral valve spacer and implantation system and method thereof |
EP3212250A4 (en) | 2014-10-31 | 2018-07-11 | Thoratec Corporation | Apical connectors and instruments for use in a heart wall |
US9789294B2 (en) | 2015-10-07 | 2017-10-17 | Edwards Lifesciences Corporation | Expandable cardiac shunt |
US10159820B2 (en) | 2016-03-30 | 2018-12-25 | Covidien Lp | Anatomical structure access |
US10894116B2 (en) | 2016-08-22 | 2021-01-19 | Tc1 Llc | Heart pump cuff |
WO2018156897A1 (en) | 2017-02-24 | 2018-08-30 | Tc1 Llc | Minimally invasive methods and devices for ventricular assist device implantation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4976691A (en) * | 1989-01-23 | 1990-12-11 | Harvinder Sahota | Topless catheters |
US5131406A (en) * | 1989-09-20 | 1992-07-21 | Martin Kaltenbach | Guide for introduction of catheters into blood vessels and the like |
US5715818A (en) * | 1993-11-03 | 1998-02-10 | Daig Corporation | Method of using a guiding introducer for left atrium |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2127903A (en) | 1936-05-05 | 1938-08-23 | Davis & Geck Inc | Tube for surgical purposes and method of preparing and using the same |
US2453056A (en) | 1947-03-12 | 1948-11-02 | Zack William Edwin | Surgical anastomosis apparatus and method |
US3042021A (en) | 1958-11-25 | 1962-07-03 | Read Thane | Bypass type insert plug for body passageway |
US3316914A (en) | 1963-02-14 | 1967-05-02 | Michael B Collito | Surgical methods and devices for anastomosis |
US3540451A (en) | 1967-02-28 | 1970-11-17 | William V Zeman | Drainage cannula with tissue connecting assemblies on both ends |
US3774615A (en) | 1971-02-08 | 1973-11-27 | Ceskoslovenska Akademie Ved | Device for connecting or joining the ends of interrupted tubular organs in surgical operations without stitching |
US4300244A (en) | 1979-09-19 | 1981-11-17 | Carbomedics, Inc. | Cardiovascular grafts |
US4366819A (en) | 1980-11-17 | 1983-01-04 | Kaster Robert L | Anastomotic fitting |
US4400833A (en) | 1981-06-10 | 1983-08-30 | Kurland Kenneth Z | Means and method of implanting bioprosthetics |
US4546499A (en) | 1982-12-13 | 1985-10-15 | Possis Medical, Inc. | Method of supplying blood to blood receiving vessels |
US4523592A (en) | 1983-04-25 | 1985-06-18 | Rollin K. Daniel P.S.C. | Anastomotic coupling means capable of end-to-end and end-to-side anastomosis |
US4728328A (en) | 1984-10-19 | 1988-03-01 | Research Corporation | Cuffed tubular organic prostheses |
US4769031A (en) | 1986-06-25 | 1988-09-06 | Mcgough Edwin C | Ventricular access device and method |
NL8700667A (en) | 1987-03-20 | 1988-10-17 | Rogier Guido Marie Biemans | ENDOVASCULAR CONNECTOR. |
US4769029A (en) | 1987-06-19 | 1988-09-06 | Patel Jayendrakumar I | Prosthetic graft for arterial system repair |
SU1754128A1 (en) | 1989-03-06 | 1992-08-15 | Харьковский научно-исследовательский институт общей и неотложной хирургии | Method for treating the myocardial ischemia |
US4995857A (en) | 1989-04-07 | 1991-02-26 | Arnold John R | Left ventricular assist device and method for temporary and permanent procedures |
US4955899A (en) | 1989-05-26 | 1990-09-11 | Impra, Inc. | Longitudinally compliant vascular graft |
CA2033195C (en) | 1989-06-19 | 1994-11-15 | Hugh H. Trout, Iii | Aortic graft and method for repairing aneurysm |
US4955856A (en) | 1989-06-30 | 1990-09-11 | Phillips Steven J | Method and apparatus for installing a ventricular assist device cannulae |
EP0416734B1 (en) * | 1989-08-09 | 1995-06-14 | C.R. Bard, Inc. | Guide catheter and guidewires for effecting rapid catheter exchange |
US5571169A (en) | 1993-06-07 | 1996-11-05 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
US5078735A (en) | 1990-06-18 | 1992-01-07 | Mobin Uddin Kazi | Prosthetic grafting method for bypass surgery |
US5054484A (en) | 1990-11-21 | 1991-10-08 | Hebeler Jr Robert F | Tracheostomy device |
US5380316A (en) | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5250058A (en) | 1991-01-17 | 1993-10-05 | Ethicon, Inc. | Absorbable anastomosic fastener means |
CA2060067A1 (en) * | 1991-01-28 | 1992-07-29 | Lilip Lau | Stent delivery system |
ATE175568T1 (en) | 1991-07-04 | 1999-01-15 | Earl Ronald Owen | TUBULAR SURGICAL IMPLANT |
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
FR2685208B1 (en) | 1991-12-23 | 1998-02-27 | Ela Medical Sa | VENTRICULAR CANNULA DEVICE. |
US5327913A (en) | 1992-03-25 | 1994-07-12 | Taheri Syde A | Percutaneus cardiomyoplasty method |
US5758663A (en) | 1992-04-10 | 1998-06-02 | Wilk; Peter J. | Coronary artery by-pass method |
US5254113A (en) | 1992-08-31 | 1993-10-19 | Wilk Peter J | Anastomosis method |
US5409019A (en) | 1992-10-30 | 1995-04-25 | Wilk; Peter J. | Coronary artery by-pass method |
US5287861A (en) | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5429144A (en) | 1992-10-30 | 1995-07-04 | Wilk; Peter J. | Coronary artery by-pass method |
US5716395A (en) | 1992-12-11 | 1998-02-10 | W.L. Gore & Associates, Inc. | Prosthetic vascular graft |
US5318527A (en) * | 1992-12-22 | 1994-06-07 | Advanced Cardiovascular Systems, Inc. | Fixed wire catheter exchange device |
WO1994021197A1 (en) | 1993-03-25 | 1994-09-29 | C.R. Bard, Inc. | Vascular graft |
US5913894A (en) | 1994-12-05 | 1999-06-22 | Meadox Medicals, Inc. | Solid woven tubular prosthesis |
CA2169549C (en) | 1993-08-18 | 2000-07-11 | James D. Lewis | A tubular intraluminal graft |
AU1091095A (en) | 1993-11-08 | 1995-05-29 | Harrison M. Lazarus | Intraluminal vascular graft and method |
US5503635A (en) | 1993-11-12 | 1996-04-02 | United States Surgical Corporation | Apparatus and method for performing compressional anastomoses |
US5443497A (en) | 1993-11-22 | 1995-08-22 | The Johns Hopkins University | Percutaneous prosthetic by-pass graft and method of use |
US5527353A (en) | 1993-12-02 | 1996-06-18 | Meadox Medicals, Inc. | Implantable tubular prosthesis |
US5466242A (en) | 1994-02-02 | 1995-11-14 | Mori; Katsushi | Stent for biliary, urinary or vascular system |
US5591226A (en) | 1995-01-23 | 1997-01-07 | Schneider (Usa) Inc. | Percutaneous stent-graft and method for delivery thereof |
US5904697A (en) | 1995-02-24 | 1999-05-18 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5695504A (en) | 1995-02-24 | 1997-12-09 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5888247A (en) | 1995-04-10 | 1999-03-30 | Cardiothoracic Systems, Inc | Method for coronary artery bypass |
US6616675B1 (en) | 1996-02-02 | 2003-09-09 | Transvascular, Inc. | Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures |
US6190353B1 (en) | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
DE69638011D1 (en) | 1995-10-13 | 2009-10-08 | Medtronic Vascular Inc | NGRIFF |
JP2001508318A (en) | 1996-02-02 | 2001-06-26 | トランスバスキュラー インコーポレイテッド | Apparatus, systems and methods for interstitial transvascular intervention |
AU733332B2 (en) | 1996-02-02 | 2001-05-10 | Transvascular, Inc. | Methods and apparatus for blocking flow through blood vessels |
JPH09215753A (en) | 1996-02-08 | 1997-08-19 | Schneider Usa Inc | Self-expanding stent made of titanium alloy |
US5810836A (en) | 1996-03-04 | 1998-09-22 | Myocardial Stents, Inc. | Device and method for trans myocardial revascularization (TMR) |
US5665103A (en) | 1996-03-07 | 1997-09-09 | Scimed Life Systems, Inc. | Stent locating device |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US5662124A (en) | 1996-06-19 | 1997-09-02 | Wilk Patent Development Corp. | Coronary artery by-pass method |
FR2750853B1 (en) | 1996-07-10 | 1998-12-18 | Braun Celsa Sa | MEDICAL PROSTHESIS, IN PARTICULAR FOR ANEVRISMS, WITH PERFECTIONED CONNECTION BETWEEN ITS SHEATH AND ITS STRUCTURE |
FR2751867B1 (en) | 1996-08-05 | 1999-05-21 | Leriche Rene Ass | PROSTHESIS COLLERETTE |
US5755682A (en) | 1996-08-13 | 1998-05-26 | Heartstent Corporation | Method and apparatus for performing coronary artery bypass surgery |
WO1998008456A1 (en) | 1996-08-26 | 1998-03-05 | Transvascular, Inc. | Methods and apparatus for transmyocardial direct coronary revascularization |
US5655548A (en) | 1996-09-16 | 1997-08-12 | Circulation, Inc. | Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion |
AU1275997A (en) | 1996-10-11 | 1998-05-11 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
US5976178A (en) | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
US5971993A (en) | 1996-11-07 | 1999-10-26 | Myocardial Stents, Inc. | System for delivery of a trans myocardial device to a heart wall |
US5941908A (en) | 1997-04-23 | 1999-08-24 | Vascular Science, Inc. | Artificial medical graft with a releasable retainer |
WO1998019625A2 (en) | 1996-11-08 | 1998-05-14 | Houser Russell A | Percutaneous bypass graft and securing system |
US5875782A (en) | 1996-11-14 | 1999-03-02 | Cardiothoracic Systems, Inc. | Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass |
US5910150A (en) | 1996-12-02 | 1999-06-08 | Angiotrax, Inc. | Apparatus for performing surgery |
US5897587A (en) | 1996-12-03 | 1999-04-27 | Atrium Medical Corporation | Multi-stage prosthesis |
US5879321A (en) | 1997-01-22 | 1999-03-09 | The University Of Kentucky Research Foundation | Portocaval-right atrial shunt |
US5916226A (en) | 1997-02-03 | 1999-06-29 | Tozzi; Piergiorgio | Apparatus and method for improved sutureless anastomosis |
US5715878A (en) * | 1997-02-10 | 1998-02-10 | Ondish; Andrew | Jig for a molder-planar |
US5855597A (en) | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
DE19720115C2 (en) | 1997-05-14 | 1999-05-20 | Jomed Implantate Gmbh | Stent graft |
US6092526A (en) | 1997-06-19 | 2000-07-25 | Scimed Life Systems, Inc. | Percutaneous chamber-to-artery bypass |
US5908029A (en) | 1997-08-15 | 1999-06-01 | Heartstent Corporation | Coronary artery bypass with reverse flow |
US5984956A (en) | 1997-10-06 | 1999-11-16 | Heartstent Corporation | Transmyocardial implant |
US6001124A (en) | 1997-10-09 | 1999-12-14 | Vascular Science, Inc. | Oblique-angle graft connectors |
US6076529A (en) | 1998-04-20 | 2000-06-20 | Heartstent Corporation | Transmyocardial implant with inserted vessel |
US6029672A (en) | 1998-04-20 | 2000-02-29 | Heartstent Corporation | Transmyocardial implant procedure and tools |
US5989287A (en) | 1998-05-06 | 1999-11-23 | Av Healing Llc | Vascular graft assemblies and methods for implanting same |
US5980567A (en) | 1998-07-04 | 1999-11-09 | Paul William Jordan | Connecting device for natural arteries with artificial arteries |
US6053942A (en) | 1998-08-18 | 2000-04-25 | Heartstent Corporation | Transmyocardial implant with coronary stent |
-
1998
- 1998-10-13 US US09/170,793 patent/US6808498B2/en not_active Expired - Fee Related
-
1999
- 1999-10-12 JP JP2000575420A patent/JP2002527135A/en not_active Withdrawn
- 1999-10-12 AU AU12002/00A patent/AU764910B2/en not_active Ceased
- 1999-10-12 EP EP99970305A patent/EP1121050A1/en not_active Withdrawn
- 1999-10-12 WO PCT/US1999/022945 patent/WO2000021436A1/en not_active Application Discontinuation
- 1999-10-12 CA CA002347727A patent/CA2347727A1/en not_active Abandoned
-
2004
- 2004-02-23 US US10/784,861 patent/US20040167444A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4976691A (en) * | 1989-01-23 | 1990-12-11 | Harvinder Sahota | Topless catheters |
US5131406A (en) * | 1989-09-20 | 1992-07-21 | Martin Kaltenbach | Guide for introduction of catheters into blood vessels and the like |
US5715818A (en) * | 1993-11-03 | 1998-02-10 | Daig Corporation | Method of using a guiding introducer for left atrium |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US7736327B2 (en) | 1998-09-10 | 2010-06-15 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US8216174B2 (en) | 1998-09-10 | 2012-07-10 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US8597226B2 (en) | 1998-09-10 | 2013-12-03 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6302892B1 (en) | 1999-08-04 | 2001-10-16 | Percardia, Inc. | Blood flow conduit delivery system and method of use |
US7727268B2 (en) | 2003-07-17 | 2010-06-01 | Medtronic Vascular, Inc. | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US8156942B2 (en) | 2003-07-22 | 2012-04-17 | Medtronic Vascular, Inc. | Method of implanting a transmyocardial stent |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
Also Published As
Publication number | Publication date |
---|---|
CA2347727A1 (en) | 2000-04-20 |
EP1121050A1 (en) | 2001-08-08 |
US20020077566A1 (en) | 2002-06-20 |
AU764910B2 (en) | 2003-09-04 |
AU1200200A (en) | 2000-05-01 |
US6808498B2 (en) | 2004-10-26 |
JP2002527135A (en) | 2002-08-27 |
US20040167444A1 (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6808498B2 (en) | Placing a guide member into a heart chamber through a coronary vessel and delivering devices for placing the coronary vessel in communication with the heart chamber | |
US7137962B2 (en) | Devices and methods for use in performing transmyocardial coronary bypass | |
US7025773B2 (en) | Methods and devices for placing a conduit in fluid communication with a target vessel | |
US7578828B2 (en) | Methods and devices for placing a conduit in fluid communication with a target vessel | |
US7214234B2 (en) | Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication | |
AU772615B2 (en) | Methods and devices for placing a conduit in fluid communication with a target vessel | |
US20050043781A1 (en) | Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart | |
US20100114306A1 (en) | Cardiovascular procedures | |
US20070010781A1 (en) | Implantable aorto-coronary sinus shunt for myocardial revascularization | |
AU2003234967A1 (en) | Devices and methods for use in performing transmyocardial coronary bypass | |
JP2002542873A (en) | Method and device for forming a conduit between a target vessel and a blood source |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 12002 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2347727 Country of ref document: CA Ref country code: CA Ref document number: 2347727 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12002/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 575420 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999970305 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999970305 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 12002/00 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999970305 Country of ref document: EP |